A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The PEPCAD-DES study

Journal of the American College of Cardiology

Volumn 59, Issue 15, 2012, Pages 1377-1382

  Rittger, Harald ^a   Brachmann, Johannes ^b   Sinha, Anil M ^c   Waliszewski, Matthias ^d   Ohlow, Marc ^e   Brugger, Andreas ^f   Thiele, Holger ^g   Birkemeyer, Ralf ^h   Kurowski, Volkhard ⁱ   Breithardt, Ole A ^a   Schmidt, Martin ^j   Zimmermann, Stefan ^a   Lonke, Sandra ^a   Von Cranach, Moritz ^a   Nguyen, The Vinh ^k   Daniel, Werner G ^a   Whrle, Jochen ^k  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b KLINIKUM COBURG   (Germany)

^c Klinikum Hof   (Germany)

^d B Braun Melsungen AG   (Germany)

^e Klinik fur Kardiologie   (Germany)

^f Klinikum Kulmbach   (Germany)

^g UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^h SCHWARZWALD BAAR KLINIKUM   (Germany)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j Chirurgische Klinik Munchen Bogenhausen   (Germany)

^k UNIVERSITY OF ULM   (Germany)

more..

Author keywords

balloon angioplasty; drug coated balloon; drug eluting stent; in stent restenosis

Indexed keywords

PACLITAXEL;

ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THERAPY EFFECT;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84859426601     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.01.015     Document Type: Article

References (16)

1. C. Stettler, S. Wandel, S. Allemann Outcomes associated with drug-eluting and bare-metal stents: a collaborative network metaanalysis Lancet 370 2007 937 948
2. J. Whrle, T. Nusser, H.A. Kestler, M. Kochs, V. Hombach Comparison of the slow-release paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions Clin Res Cardiol 96 2007 70 76
3. J.M. Stolker, K.F. Kennedy, J.B. Lindsey Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of risk model from the EVENT registry Circ Cardiovasc Interv 3 2010 327 334
4. J. Whrle, W. Rottbauer, A. Imhof Everolimus-eluting stents for the treatment of chronic total coronary occlusions Clin Res Cardiol 101 2012 23 28
5. B. Scheller, C. Hehrlein, W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
6. M. Unverdorben, C. Vallbracht, B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
7. J. Whrle, R. Birkemeyer, S. Markovic Prospective randomized trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease Heart 16 2011 1338 1342
8. R. Mehran, G. Dangas, A.S. Abizaid Angiographic patterns of in-stent restenosis Classification and implications for long-term outcome Circulation 100 1999 1872 1878
9. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
10. B. Scheller, C. Hehrlein, W. Bocksch Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
11. S. Habara, K. Mitsudo, K. Kadota Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis J Am Coll Cardiol Intv 4 2011 149 154
12. S. Garg, K. Smith, R. Torguson Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent Catheter Cardiovasc Interv 70 2007 9 14
13. G.J. Mishkel, A.L. Moore, S. Markwell, M.C. Shelton, M.E. Shelton Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents J Am Coll Cardiol 49 2007 181 184
14. J. Mehilli, R.A. Byrne, K. Tiroch Randomized trial of paclitaxel versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
15. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, R. Mehran In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
16. F. Tagliareni, A. La Manna, F. Saia, A. Marzocchi, C. Tamburino Long-term clinical follow-up of drug-eluting stent restenosis treatment: retrospective analysis from two high volume catheterization laboratories EuroIntervention 5 2010 703 708